nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—epilepsy syndrome	0.162	0.529	CbGaD
Bismuth Subsalicylate—ALB—epilepsy syndrome	0.145	0.471	CbGaD
Bismuth Subsalicylate—ALB—Oxcarbazepine—epilepsy syndrome	0.0682	0.166	CbGbCtD
Bismuth Subsalicylate—ALB—Fosphenytoin—epilepsy syndrome	0.0596	0.145	CbGbCtD
Bismuth Subsalicylate—ALB—Clonazepam—epilepsy syndrome	0.0539	0.131	CbGbCtD
Bismuth Subsalicylate—ALB—Rufinamide—epilepsy syndrome	0.0439	0.107	CbGbCtD
Bismuth Subsalicylate—PTGS1—Diazepam—epilepsy syndrome	0.0434	0.106	CbGbCtD
Bismuth Subsalicylate—ALB—Phenytoin—epilepsy syndrome	0.0384	0.0936	CbGbCtD
Bismuth Subsalicylate—ALB—Propofol—epilepsy syndrome	0.0358	0.0873	CbGbCtD
Bismuth Subsalicylate—PTGS1—Valproic Acid—epilepsy syndrome	0.0343	0.0835	CbGbCtD
Bismuth Subsalicylate—ALB—Diazepam—epilepsy syndrome	0.0324	0.0791	CbGbCtD
Bismuth Subsalicylate—TF—pons—epilepsy syndrome	0.00936	0.227	CbGeAlD
Bismuth Subsalicylate—TF—ganglion—epilepsy syndrome	0.00479	0.116	CbGeAlD
Bismuth Subsalicylate—TF—hindbrain—epilepsy syndrome	0.00364	0.0881	CbGeAlD
Bismuth Subsalicylate—TF—brainstem—epilepsy syndrome	0.00208	0.0505	CbGeAlD
Bismuth Subsalicylate—TF—forebrain—epilepsy syndrome	0.00201	0.0487	CbGeAlD
Bismuth Subsalicylate—TF—telencephalon—epilepsy syndrome	0.00185	0.0448	CbGeAlD
Bismuth Subsalicylate—TF—medulla oblongata—epilepsy syndrome	0.00145	0.0352	CbGeAlD
Bismuth Subsalicylate—PTGS1—ganglion—epilepsy syndrome	0.00142	0.0344	CbGeAlD
Bismuth Subsalicylate—TF—midbrain—epilepsy syndrome	0.00133	0.0322	CbGeAlD
Bismuth Subsalicylate—TF—spinal cord—epilepsy syndrome	0.0013	0.0314	CbGeAlD
Bismuth Subsalicylate—TF—head—epilepsy syndrome	0.00115	0.0279	CbGeAlD
Bismuth Subsalicylate—TF—nervous system—epilepsy syndrome	0.00109	0.0264	CbGeAlD
Bismuth Subsalicylate—TF—central nervous system—epilepsy syndrome	0.00105	0.0255	CbGeAlD
Bismuth Subsalicylate—TF—cerebellum—epilepsy syndrome	0.00103	0.0249	CbGeAlD
Bismuth Subsalicylate—TF—brain—epilepsy syndrome	0.000834	0.0202	CbGeAlD
Bismuth Subsalicylate—PTGS1—forebrain—epilepsy syndrome	0.000596	0.0144	CbGeAlD
Bismuth Subsalicylate—PTGS2—forebrain—epilepsy syndrome	0.00057	0.0138	CbGeAlD
Bismuth Subsalicylate—PTGS1—telencephalon—epilepsy syndrome	0.000548	0.0133	CbGeAlD
Bismuth Subsalicylate—PTGS2—telencephalon—epilepsy syndrome	0.000524	0.0127	CbGeAlD
Bismuth Subsalicylate—ALB—brain—epilepsy syndrome	0.000434	0.0105	CbGeAlD
Bismuth Subsalicylate—PTGS2—medulla oblongata—epilepsy syndrome	0.000412	0.00997	CbGeAlD
Bismuth Subsalicylate—PTGS1—spinal cord—epilepsy syndrome	0.000384	0.0093	CbGeAlD
Bismuth Subsalicylate—PTGS2—midbrain—epilepsy syndrome	0.000376	0.00912	CbGeAlD
Bismuth Subsalicylate—PTGS2—spinal cord—epilepsy syndrome	0.000367	0.00889	CbGeAlD
Bismuth Subsalicylate—PTGS1—head—epilepsy syndrome	0.000341	0.00827	CbGeAlD
Bismuth Subsalicylate—PTGS2—head—epilepsy syndrome	0.000326	0.0079	CbGeAlD
Bismuth Subsalicylate—PTGS1—nervous system—epilepsy syndrome	0.000324	0.00784	CbGeAlD
Bismuth Subsalicylate—PTGS1—central nervous system—epilepsy syndrome	0.000312	0.00755	CbGeAlD
Bismuth Subsalicylate—PTGS2—nervous system—epilepsy syndrome	0.000309	0.00749	CbGeAlD
Bismuth Subsalicylate—PTGS2—central nervous system—epilepsy syndrome	0.000298	0.00721	CbGeAlD
Bismuth Subsalicylate—PTGS2—cerebellum—epilepsy syndrome	0.000291	0.00705	CbGeAlD
Bismuth Subsalicylate—PTGS1—brain—epilepsy syndrome	0.000247	0.00599	CbGeAlD
Bismuth Subsalicylate—PTGS2—brain—epilepsy syndrome	0.000236	0.00573	CbGeAlD
Bismuth Subsalicylate—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000173	0.00107	CcSEcCtD
Bismuth Subsalicylate—Nausea—Clobazam—epilepsy syndrome	0.000173	0.00107	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000173	0.00107	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Phenytoin—epilepsy syndrome	0.000172	0.00107	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000172	0.00107	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Felbamate—epilepsy syndrome	0.000172	0.00107	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Lamotrigine—epilepsy syndrome	0.000172	0.00107	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Acetazolamide—epilepsy syndrome	0.000172	0.00107	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Diazepam—epilepsy syndrome	0.000172	0.00106	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000171	0.00106	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Clonazepam—epilepsy syndrome	0.000171	0.00106	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Propofol—epilepsy syndrome	0.000171	0.00106	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Pregabalin—epilepsy syndrome	0.00017	0.00106	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Phenytoin—epilepsy syndrome	0.00017	0.00106	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000169	0.00105	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Topiramate—epilepsy syndrome	0.000169	0.00105	CcSEcCtD
Bismuth Subsalicylate—Pain—Clonazepam—epilepsy syndrome	0.000169	0.00105	CcSEcCtD
Bismuth Subsalicylate—Constipation—Clonazepam—epilepsy syndrome	0.000169	0.00105	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000169	0.00105	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Gabapentin—epilepsy syndrome	0.000168	0.00104	CcSEcCtD
Bismuth Subsalicylate—Constipation—Phenytoin—epilepsy syndrome	0.000167	0.00104	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Midazolam—epilepsy syndrome	0.000167	0.00104	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Gabapentin—epilepsy syndrome	0.000167	0.00103	CcSEcCtD
Bismuth Subsalicylate—Pain—Oxcarbazepine—epilepsy syndrome	0.000167	0.00103	CcSEcCtD
Bismuth Subsalicylate—Constipation—Oxcarbazepine—epilepsy syndrome	0.000167	0.00103	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Carbamazepine—epilepsy syndrome	0.000166	0.00103	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Felbamate—epilepsy syndrome	0.000166	0.00103	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Felbamate—epilepsy syndrome	0.000165	0.00102	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Acetazolamide—epilepsy syndrome	0.000165	0.00102	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Propofol—epilepsy syndrome	0.000165	0.00102	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Levetiracetam—epilepsy syndrome	0.000165	0.00102	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000165	0.00102	CcSEcCtD
Bismuth Subsalicylate—Headache—Acetazolamide—epilepsy syndrome	0.000163	0.00101	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Zonisamide—epilepsy syndrome	0.000163	0.00101	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000163	0.00101	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000162	0.00101	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Zonisamide—epilepsy syndrome	0.000162	0.001	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000161	0.001	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Lamotrigine—epilepsy syndrome	0.000161	0.000996	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000161	0.000995	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Topiramate—epilepsy syndrome	0.00016	0.000994	CcSEcCtD
Bismuth Subsalicylate—Pain—Carbamazepine—epilepsy syndrome	0.00016	0.000991	CcSEcCtD
Bismuth Subsalicylate—Constipation—Carbamazepine—epilepsy syndrome	0.00016	0.000991	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Propofol—epilepsy syndrome	0.00016	0.000989	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Levetiracetam—epilepsy syndrome	0.00016	0.000989	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Fosphenytoin—epilepsy syndrome	0.000159	0.000987	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000159	0.000986	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000158	0.000982	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000157	0.000974	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Clonazepam—epilepsy syndrome	0.000157	0.000971	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Gabapentin—epilepsy syndrome	0.000156	0.000968	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Midazolam—epilepsy syndrome	0.000156	0.000968	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Clonazepam—epilepsy syndrome	0.000156	0.000966	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Pregabalin—epilepsy syndrome	0.000156	0.000966	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Phenytoin—epilepsy syndrome	0.000156	0.000965	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Vigabatrin—epilepsy syndrome	0.000155	0.000962	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Phenytoin—epilepsy syndrome	0.000155	0.00096	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000155	0.00096	CcSEcCtD
Bismuth Subsalicylate—Pain—Lamotrigine—epilepsy syndrome	0.000155	0.000958	CcSEcCtD
Bismuth Subsalicylate—Constipation—Lamotrigine—epilepsy syndrome	0.000155	0.000958	CcSEcCtD
Bismuth Subsalicylate—Nausea—Acetazolamide—epilepsy syndrome	0.000154	0.000957	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Levetiracetam—epilepsy syndrome	0.000154	0.000956	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000154	0.000955	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000154	0.000955	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000154	0.000955	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Propofol—epilepsy syndrome	0.000153	0.000951	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Diazepam—epilepsy syndrome	0.000153	0.000947	CcSEcCtD
Bismuth Subsalicylate—Rash—Propofol—epilepsy syndrome	0.000152	0.000943	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Propofol—epilepsy syndrome	0.000152	0.000943	CcSEcCtD
Bismuth Subsalicylate—Headache—Propofol—epilepsy syndrome	0.000151	0.000937	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Midazolam—epilepsy syndrome	0.00015	0.000931	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00015	0.000931	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000149	0.000923	CcSEcCtD
Bismuth Subsalicylate—Rash—Midazolam—epilepsy syndrome	0.000149	0.000923	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Fosphenytoin—epilepsy syndrome	0.000149	0.000923	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Midazolam—epilepsy syndrome	0.000149	0.000922	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Carbamazepine—epilepsy syndrome	0.000149	0.000921	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Levetiracetam—epilepsy syndrome	0.000148	0.000919	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Topiramate—epilepsy syndrome	0.000148	0.000918	CcSEcCtD
Bismuth Subsalicylate—Headache—Midazolam—epilepsy syndrome	0.000148	0.000917	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Felbamate—epilepsy syndrome	0.000148	0.000917	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000148	0.000916	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Diazepam—epilepsy syndrome	0.000148	0.000916	CcSEcCtD
Bismuth Subsalicylate—Rash—Levetiracetam—epilepsy syndrome	0.000147	0.000912	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Levetiracetam—epilepsy syndrome	0.000147	0.000911	CcSEcCtD
Bismuth Subsalicylate—Headache—Levetiracetam—epilepsy syndrome	0.000146	0.000906	CcSEcCtD
Bismuth Subsalicylate—Erythema—Gabapentin—epilepsy syndrome	0.000146	0.000904	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vigabatrin—epilepsy syndrome	0.000145	0.000899	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Valproic Acid—epilepsy syndrome	0.000145	0.000898	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Zonisamide—epilepsy syndrome	0.000145	0.000897	CcSEcCtD
Bismuth Subsalicylate—Oedema—Valproic Acid—epilepsy syndrome	0.000144	0.00089	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Lamotrigine—epilepsy syndrome	0.000144	0.00089	CcSEcCtD
Bismuth Subsalicylate—Nausea—Propofol—epilepsy syndrome	0.000143	0.000889	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Fosphenytoin—epilepsy syndrome	0.000143	0.000887	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Felbamate—epilepsy syndrome	0.000143	0.000887	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000143	0.000886	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Gabapentin—epilepsy syndrome	0.000143	0.000886	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Diazepam—epilepsy syndrome	0.000143	0.000885	CcSEcCtD
Bismuth Subsalicylate—Infection—Valproic Acid—epilepsy syndrome	0.000143	0.000884	CcSEcCtD
Bismuth Subsalicylate—Rash—Fosphenytoin—epilepsy syndrome	0.000142	0.00088	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000142	0.000879	CcSEcCtD
Bismuth Subsalicylate—Headache—Fosphenytoin—epilepsy syndrome	0.000141	0.000874	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Topiramate—epilepsy syndrome	0.000141	0.000874	CcSEcCtD
Bismuth Subsalicylate—Nausea—Midazolam—epilepsy syndrome	0.00014	0.00087	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Topiramate—epilepsy syndrome	0.00014	0.00087	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Zonisamide—epilepsy syndrome	0.00014	0.000868	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Clonazepam—epilepsy syndrome	0.00014	0.000865	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vigabatrin—epilepsy syndrome	0.000139	0.000865	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Phenytoin—epilepsy syndrome	0.000139	0.000859	CcSEcCtD
Bismuth Subsalicylate—Nausea—Levetiracetam—epilepsy syndrome	0.000139	0.000859	CcSEcCtD
Bismuth Subsalicylate—Rash—Vigabatrin—epilepsy syndrome	0.000138	0.000858	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Felbamate—epilepsy syndrome	0.000138	0.000857	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000138	0.000857	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000138	0.000855	CcSEcCtD
Bismuth Subsalicylate—Headache—Vigabatrin—epilepsy syndrome	0.000137	0.000852	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Diazepam—epilepsy syndrome	0.000137	0.000851	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Valproic Acid—epilepsy syndrome	0.000137	0.000849	CcSEcCtD
Bismuth Subsalicylate—Rash—Diazepam—epilepsy syndrome	0.000136	0.000844	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Diazepam—epilepsy syndrome	0.000136	0.000843	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Zonisamide—epilepsy syndrome	0.000135	0.000839	CcSEcCtD
Bismuth Subsalicylate—Headache—Diazepam—epilepsy syndrome	0.000135	0.000839	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Clonazepam—epilepsy syndrome	0.000135	0.000836	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Phenytoin—epilepsy syndrome	0.000134	0.000831	CcSEcCtD
Bismuth Subsalicylate—Nausea—Fosphenytoin—epilepsy syndrome	0.000134	0.000829	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000133	0.000826	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Topiramate—epilepsy syndrome	0.000133	0.000826	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Felbamate—epilepsy syndrome	0.000133	0.000824	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Carbamazepine—epilepsy syndrome	0.000132	0.00082	CcSEcCtD
Bismuth Subsalicylate—Rash—Felbamate—epilepsy syndrome	0.000132	0.000817	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Felbamate—epilepsy syndrome	0.000132	0.000816	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Topiramate—epilepsy syndrome	0.000131	0.000815	CcSEcCtD
Bismuth Subsalicylate—Headache—Felbamate—epilepsy syndrome	0.000131	0.000812	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Pregabalin—epilepsy syndrome	0.000131	0.000811	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Clonazepam—epilepsy syndrome	0.00013	0.000808	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vigabatrin—epilepsy syndrome	0.00013	0.000808	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Zonisamide—epilepsy syndrome	0.00013	0.000807	CcSEcCtD
Bismuth Subsalicylate—Oedema—Pregabalin—epilepsy syndrome	0.00013	0.000805	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Phenytoin—epilepsy syndrome	0.00013	0.000803	CcSEcCtD
Bismuth Subsalicylate—Rash—Zonisamide—epilepsy syndrome	0.000129	0.0008	CcSEcCtD
Bismuth Subsalicylate—Infection—Pregabalin—epilepsy syndrome	0.000129	0.0008	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Zonisamide—epilepsy syndrome	0.000129	0.000799	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000129	0.000799	CcSEcCtD
Bismuth Subsalicylate—Nausea—Diazepam—epilepsy syndrome	0.000128	0.000795	CcSEcCtD
Bismuth Subsalicylate—Headache—Zonisamide—epilepsy syndrome	0.000128	0.000795	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000128	0.000793	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Lamotrigine—epilepsy syndrome	0.000128	0.000793	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Valproic Acid—epilepsy syndrome	0.000128	0.000791	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000126	0.000784	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Clonazepam—epilepsy syndrome	0.000125	0.000777	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000125	0.000774	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Phenytoin—epilepsy syndrome	0.000125	0.000772	CcSEcCtD
Bismuth Subsalicylate—Rash—Clonazepam—epilepsy syndrome	0.000124	0.000771	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Clonazepam—epilepsy syndrome	0.000124	0.00077	CcSEcCtD
Bismuth Subsalicylate—Nausea—Felbamate—epilepsy syndrome	0.000124	0.00077	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000124	0.000768	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Pregabalin—epilepsy syndrome	0.000124	0.000767	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Carbamazepine—epilepsy syndrome	0.000124	0.000767	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000124	0.000767	CcSEcCtD
Bismuth Subsalicylate—Headache—Clonazepam—epilepsy syndrome	0.000124	0.000766	CcSEcCtD
Bismuth Subsalicylate—Rash—Phenytoin—epilepsy syndrome	0.000123	0.000766	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Phenytoin—epilepsy syndrome	0.000123	0.000765	CcSEcCtD
Bismuth Subsalicylate—Rash—Oxcarbazepine—epilepsy syndrome	0.000123	0.000762	CcSEcCtD
Bismuth Subsalicylate—Pain—Valproic Acid—epilepsy syndrome	0.000123	0.000761	CcSEcCtD
Bismuth Subsalicylate—Constipation—Valproic Acid—epilepsy syndrome	0.000123	0.000761	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000123	0.000761	CcSEcCtD
Bismuth Subsalicylate—Headache—Phenytoin—epilepsy syndrome	0.000123	0.000761	CcSEcCtD
Bismuth Subsalicylate—Erythema—Topiramate—epilepsy syndrome	0.000123	0.000761	CcSEcCtD
Bismuth Subsalicylate—Headache—Oxcarbazepine—epilepsy syndrome	0.000122	0.000757	CcSEcCtD
Bismuth Subsalicylate—Nausea—Zonisamide—epilepsy syndrome	0.000122	0.000753	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Topiramate—epilepsy syndrome	0.00012	0.000745	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Gabapentin—epilepsy syndrome	0.00012	0.000744	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Lamotrigine—epilepsy syndrome	0.000119	0.000741	CcSEcCtD
Bismuth Subsalicylate—Oedema—Gabapentin—epilepsy syndrome	0.000119	0.000738	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Carbamazepine—epilepsy syndrome	0.000119	0.000737	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000118	0.000734	CcSEcCtD
Bismuth Subsalicylate—Infection—Gabapentin—epilepsy syndrome	0.000118	0.000733	CcSEcCtD
Bismuth Subsalicylate—Rash—Carbamazepine—epilepsy syndrome	0.000118	0.000731	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Carbamazepine—epilepsy syndrome	0.000118	0.00073	CcSEcCtD
Bismuth Subsalicylate—Nausea—Clonazepam—epilepsy syndrome	0.000117	0.000726	CcSEcCtD
Bismuth Subsalicylate—Headache—Carbamazepine—epilepsy syndrome	0.000117	0.000726	CcSEcCtD
Bismuth Subsalicylate—Nausea—Phenytoin—epilepsy syndrome	0.000116	0.000721	CcSEcCtD
Bismuth Subsalicylate—Nausea—Oxcarbazepine—epilepsy syndrome	0.000116	0.000718	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Pregabalin—epilepsy syndrome	0.000115	0.000715	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Lamotrigine—epilepsy syndrome	0.000115	0.000712	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Valproic Acid—epilepsy syndrome	0.000114	0.000707	CcSEcCtD
Bismuth Subsalicylate—Rash—Lamotrigine—epilepsy syndrome	0.000114	0.000706	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000114	0.000706	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000114	0.000704	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Gabapentin—epilepsy syndrome	0.000113	0.000703	CcSEcCtD
Bismuth Subsalicylate—Headache—Lamotrigine—epilepsy syndrome	0.000113	0.000702	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Pregabalin—epilepsy syndrome	0.000113	0.0007	CcSEcCtD
Bismuth Subsalicylate—Nausea—Carbamazepine—epilepsy syndrome	0.000111	0.000689	CcSEcCtD
Bismuth Subsalicylate—Pain—Pregabalin—epilepsy syndrome	0.000111	0.000688	CcSEcCtD
Bismuth Subsalicylate—Constipation—Pregabalin—epilepsy syndrome	0.000111	0.000688	CcSEcCtD
Bismuth Subsalicylate—Nausea—Lamotrigine—epilepsy syndrome	0.000107	0.000665	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000107	0.000663	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Gabapentin—epilepsy syndrome	0.000106	0.000656	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Gabapentin—epilepsy syndrome	0.000105	0.00065	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Gabapentin—epilepsy syndrome	0.000103	0.000642	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Pregabalin—epilepsy syndrome	0.000103	0.000639	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Pregabalin—epilepsy syndrome	0.000103	0.000636	CcSEcCtD
Bismuth Subsalicylate—Pain—Gabapentin—epilepsy syndrome	0.000102	0.000631	CcSEcCtD
Bismuth Subsalicylate—Constipation—Gabapentin—epilepsy syndrome	0.000102	0.000631	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Valproic Acid—epilepsy syndrome	0.000102	0.00063	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Topiramate—epilepsy syndrome	0.000101	0.000626	CcSEcCtD
Bismuth Subsalicylate—Oedema—Topiramate—epilepsy syndrome	0.0001	0.000621	CcSEcCtD
Bismuth Subsalicylate—Infection—Topiramate—epilepsy syndrome	9.95e-05	0.000617	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Valproic Acid—epilepsy syndrome	9.82e-05	0.000609	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Gabapentin—epilepsy syndrome	9.81e-05	0.000608	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Topiramate—epilepsy syndrome	9.55e-05	0.000592	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Valproic Acid—epilepsy syndrome	9.49e-05	0.000589	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Gabapentin—epilepsy syndrome	9.46e-05	0.000586	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Gabapentin—epilepsy syndrome	9.41e-05	0.000583	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Pregabalin—epilepsy syndrome	9.18e-05	0.000569	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Valproic Acid—epilepsy syndrome	9.13e-05	0.000566	CcSEcCtD
Bismuth Subsalicylate—Rash—Valproic Acid—epilepsy syndrome	9.05e-05	0.000561	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Valproic Acid—epilepsy syndrome	9.04e-05	0.000561	CcSEcCtD
Bismuth Subsalicylate—Headache—Valproic Acid—epilepsy syndrome	8.99e-05	0.000558	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Topiramate—epilepsy syndrome	8.9e-05	0.000552	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Pregabalin—epilepsy syndrome	8.88e-05	0.000551	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Topiramate—epilepsy syndrome	8.81e-05	0.000547	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Topiramate—epilepsy syndrome	8.71e-05	0.00054	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Pregabalin—epilepsy syndrome	8.58e-05	0.000532	CcSEcCtD
Bismuth Subsalicylate—Constipation—Topiramate—epilepsy syndrome	8.56e-05	0.000531	CcSEcCtD
Bismuth Subsalicylate—Pain—Topiramate—epilepsy syndrome	8.56e-05	0.000531	CcSEcCtD
Bismuth Subsalicylate—Nausea—Valproic Acid—epilepsy syndrome	8.53e-05	0.000529	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Gabapentin—epilepsy syndrome	8.42e-05	0.000522	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Pregabalin—epilepsy syndrome	8.25e-05	0.000512	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Topiramate—epilepsy syndrome	8.25e-05	0.000512	CcSEcCtD
Bismuth Subsalicylate—Rash—Pregabalin—epilepsy syndrome	8.18e-05	0.000507	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Pregabalin—epilepsy syndrome	8.18e-05	0.000507	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Gabapentin—epilepsy syndrome	8.14e-05	0.000505	CcSEcCtD
Bismuth Subsalicylate—Headache—Pregabalin—epilepsy syndrome	8.13e-05	0.000504	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Topiramate—epilepsy syndrome	7.96e-05	0.000493	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Topiramate—epilepsy syndrome	7.92e-05	0.000491	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Gabapentin—epilepsy syndrome	7.87e-05	0.000488	CcSEcCtD
Bismuth Subsalicylate—Nausea—Pregabalin—epilepsy syndrome	7.71e-05	0.000478	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Gabapentin—epilepsy syndrome	7.57e-05	0.000469	CcSEcCtD
Bismuth Subsalicylate—Rash—Gabapentin—epilepsy syndrome	7.51e-05	0.000465	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Gabapentin—epilepsy syndrome	7.5e-05	0.000465	CcSEcCtD
Bismuth Subsalicylate—Headache—Gabapentin—epilepsy syndrome	7.46e-05	0.000462	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Topiramate—epilepsy syndrome	7.08e-05	0.000439	CcSEcCtD
Bismuth Subsalicylate—Nausea—Gabapentin—epilepsy syndrome	7.07e-05	0.000438	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Topiramate—epilepsy syndrome	6.85e-05	0.000425	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Topiramate—epilepsy syndrome	6.62e-05	0.000411	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Topiramate—epilepsy syndrome	6.37e-05	0.000395	CcSEcCtD
Bismuth Subsalicylate—Rash—Topiramate—epilepsy syndrome	6.31e-05	0.000391	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Topiramate—epilepsy syndrome	6.31e-05	0.000391	CcSEcCtD
Bismuth Subsalicylate—Headache—Topiramate—epilepsy syndrome	6.27e-05	0.000389	CcSEcCtD
Bismuth Subsalicylate—Nausea—Topiramate—epilepsy syndrome	5.95e-05	0.000369	CcSEcCtD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.02e-05	0.000376	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SLC8A1—epilepsy syndrome	3.02e-05	0.000376	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	2.99e-05	0.000372	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CA4—epilepsy syndrome	2.99e-05	0.000372	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—QDPR—epilepsy syndrome	2.99e-05	0.000372	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	2.98e-05	0.000372	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.97e-05	0.000369	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HSD17B4—epilepsy syndrome	2.95e-05	0.000368	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STX1B—epilepsy syndrome	2.91e-05	0.000362	CbGpPWpGaD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	2.88e-05	0.000358	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GBE1—epilepsy syndrome	2.85e-05	0.000356	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPP1R3C—epilepsy syndrome	2.85e-05	0.000356	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GLUD1—epilepsy syndrome	2.84e-05	0.000354	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PDXK—epilepsy syndrome	2.84e-05	0.000354	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CERS1—epilepsy syndrome	2.84e-05	0.000354	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—FAR1—epilepsy syndrome	2.84e-05	0.000354	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—L2HGDH—epilepsy syndrome	2.84e-05	0.000354	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ADK—epilepsy syndrome	2.84e-05	0.000354	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.83e-05	0.000352	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	2.82e-05	0.000351	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—COX3—epilepsy syndrome	2.81e-05	0.00035	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	2.79e-05	0.000348	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—epilepsy syndrome	2.79e-05	0.000348	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.79e-05	0.000347	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.79e-05	0.000347	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.74e-05	0.000342	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	2.73e-05	0.00034	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.71e-05	0.000338	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CPSF4—epilepsy syndrome	2.71e-05	0.000337	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GBE1—epilepsy syndrome	2.71e-05	0.000337	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPP1R3C—epilepsy syndrome	2.71e-05	0.000337	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ASAH1—epilepsy syndrome	2.68e-05	0.000334	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	2.68e-05	0.000334	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	2.66e-05	0.000332	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	2.66e-05	0.000332	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—KCNB1—epilepsy syndrome	2.66e-05	0.000332	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PFKL—epilepsy syndrome	2.66e-05	0.000332	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	2.66e-05	0.000332	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	2.66e-05	0.000332	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	2.62e-05	0.000327	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.61e-05	0.000325	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—STXBP1—epilepsy syndrome	2.61e-05	0.000325	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.61e-05	0.000325	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.6e-05	0.000324	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GAMT—epilepsy syndrome	2.6e-05	0.000324	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—EPM2A—epilepsy syndrome	2.6e-05	0.000324	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NHLRC1—epilepsy syndrome	2.6e-05	0.000324	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PNPO—epilepsy syndrome	2.6e-05	0.000324	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.59e-05	0.000322	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NT5E—epilepsy syndrome	2.54e-05	0.000317	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALAD—epilepsy syndrome	2.54e-05	0.000317	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PPIA—epilepsy syndrome	2.53e-05	0.000316	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.52e-05	0.000314	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.52e-05	0.000314	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ATIC—epilepsy syndrome	2.44e-05	0.000304	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—UPB1—epilepsy syndrome	2.44e-05	0.000304	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NEU1—epilepsy syndrome	2.44e-05	0.000304	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALDH7A1—epilepsy syndrome	2.43e-05	0.000302	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CACNA1A—epilepsy syndrome	2.43e-05	0.000302	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	2.42e-05	0.000302	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CA4—epilepsy syndrome	2.42e-05	0.000301	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—QDPR—epilepsy syndrome	2.42e-05	0.000301	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.42e-05	0.000301	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ST3GAL3—epilepsy syndrome	2.37e-05	0.000296	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	2.35e-05	0.000292	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ADSL—epilepsy syndrome	2.33e-05	0.00029	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.31e-05	0.000288	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	2.3e-05	0.000287	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GLUL—epilepsy syndrome	2.28e-05	0.000284	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—COX3—epilepsy syndrome	2.27e-05	0.000283	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	2.27e-05	0.000282	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GBE1—epilepsy syndrome	2.27e-05	0.000282	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ST3GAL3—epilepsy syndrome	2.25e-05	0.00028	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.25e-05	0.00028	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGA2—epilepsy syndrome	2.25e-05	0.00028	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CACNA1D—epilepsy syndrome	2.24e-05	0.000279	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—AKT1—epilepsy syndrome	2.24e-05	0.000279	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.22e-05	0.000276	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.21e-05	0.000276	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	2.17e-05	0.00027	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.17e-05	0.00027	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—KCNB1—epilepsy syndrome	2.16e-05	0.000269	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PFKL—epilepsy syndrome	2.16e-05	0.000269	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLCO1A2—epilepsy syndrome	2.16e-05	0.000269	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CACNA2D2—epilepsy syndrome	2.16e-05	0.000269	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC6A8—epilepsy syndrome	2.16e-05	0.000269	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ASAH1—epilepsy syndrome	2.13e-05	0.000265	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.11e-05	0.000262	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	2.09e-05	0.000261	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.09e-05	0.000261	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—STXBP1—epilepsy syndrome	2.07e-05	0.000258	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.06e-05	0.000256	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AQP1—epilepsy syndrome	2.03e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	2.03e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NT5E—epilepsy syndrome	2.02e-05	0.000252	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALAD—epilepsy syndrome	2.02e-05	0.000252	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2e-05	0.00025	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ADRA2A—epilepsy syndrome	1.98e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NEU1—epilepsy syndrome	1.97e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—UPB1—epilepsy syndrome	1.97e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ATIC—epilepsy syndrome	1.97e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.97e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAT—epilepsy syndrome	1.97e-05	0.000245	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.95e-05	0.000243	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.93e-05	0.00024	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.93e-05	0.00024	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSD17B4—epilepsy syndrome	1.9e-05	0.000236	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.89e-05	0.000235	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS1—epilepsy syndrome	1.85e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.85e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CHRM3—epilepsy syndrome	1.84e-05	0.000229	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	1.84e-05	0.000229	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GBE1—epilepsy syndrome	1.83e-05	0.000228	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPP1R3C—epilepsy syndrome	1.83e-05	0.000228	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.81e-05	0.000226	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.79e-05	0.000223	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	1.78e-05	0.000221	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.77e-05	0.00022	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT3—epilepsy syndrome	1.73e-05	0.000216	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ASAH1—epilepsy syndrome	1.72e-05	0.000215	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.72e-05	0.000214	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.71e-05	0.000213	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAUR—epilepsy syndrome	1.71e-05	0.000213	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.7e-05	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.68e-05	0.000209	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—STXBP1—epilepsy syndrome	1.68e-05	0.000209	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	1.66e-05	0.000207	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EIF2AK2—epilepsy syndrome	1.64e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NT5E—epilepsy syndrome	1.63e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALAD—epilepsy syndrome	1.63e-05	0.000204	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.62e-05	0.000202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AQP1—epilepsy syndrome	1.61e-05	0.000201	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CDC42—epilepsy syndrome	1.58e-05	0.000197	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.56e-05	0.000194	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.56e-05	0.000194	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.55e-05	0.000193	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.53e-05	0.00019	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPIA—epilepsy syndrome	1.52e-05	0.000189	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCG2—epilepsy syndrome	1.5e-05	0.000187	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ADSL—epilepsy syndrome	1.49e-05	0.000186	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.48e-05	0.000184	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GLUL—epilepsy syndrome	1.47e-05	0.000183	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	1.46e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.46e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.46e-05	0.000182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	1.45e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.44e-05	0.00018	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.44e-05	0.000179	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—FYN—epilepsy syndrome	1.41e-05	0.000175	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.36e-05	0.000169	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.35e-05	0.000169	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.35e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.34e-05	0.000167	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.33e-05	0.000166	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.32e-05	0.000165	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.31e-05	0.000164	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	1.31e-05	0.000163	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AQP1—epilepsy syndrome	1.31e-05	0.000163	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.28e-05	0.00016	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.27e-05	0.000159	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.25e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	1.25e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—BCHE—epilepsy syndrome	1.24e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.24e-05	0.000154	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAU—epilepsy syndrome	1.2e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.19e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	1.18e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CHRM3—epilepsy syndrome	1.18e-05	0.000147	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.18e-05	0.000147	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PLCB1—epilepsy syndrome	1.17e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TH—epilepsy syndrome	1.17e-05	0.000145	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1.16e-05	0.000144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	1.15e-05	0.000144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.15e-05	0.000143	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.14e-05	0.000143	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC2A1—epilepsy syndrome	1.12e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.12e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JUNB—epilepsy syndrome	1.12e-05	0.000139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS1—epilepsy syndrome	1.11e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—epilepsy syndrome	1.1e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.1e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.1e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.08e-05	0.000134	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HBEGF—epilepsy syndrome	1.06e-05	0.000132	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.04e-05	0.00013	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.04e-05	0.00013	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT3—epilepsy syndrome	1.04e-05	0.000129	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ADAM10—epilepsy syndrome	1.01e-05	0.000126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	9.9e-06	0.000123	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BCHE—epilepsy syndrome	9.86e-06	0.000123	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMOX1—epilepsy syndrome	9.75e-06	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCG2—epilepsy syndrome	9.63e-06	0.00012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAT—epilepsy syndrome	9.62e-06	0.00012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDC42—epilepsy syndrome	9.46e-06	0.000118	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	9.41e-06	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2C19—epilepsy syndrome	9.38e-06	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCB1—epilepsy syndrome	9.36e-06	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP11A1—epilepsy syndrome	9.32e-06	0.000116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLCB1—epilepsy syndrome	9.3e-06	0.000116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TH—epilepsy syndrome	9.27e-06	0.000116	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.26e-06	0.000115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPX1—epilepsy syndrome	8.7e-06	0.000108	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HES1—epilepsy syndrome	8.66e-06	0.000108	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FYN—epilepsy syndrome	8.42e-06	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2D6—epilepsy syndrome	8.42e-06	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—H2AFX—epilepsy syndrome	8.39e-06	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—YWHAZ—epilepsy syndrome	8.09e-06	0.000101	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ADRA2A—epilepsy syndrome	8.01e-06	9.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BCHE—epilepsy syndrome	7.98e-06	9.94e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	7.91e-06	9.85e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CCR5—epilepsy syndrome	7.79e-06	9.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMOX1—epilepsy syndrome	7.74e-06	9.64e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAT—epilepsy syndrome	7.63e-06	9.51e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AGT—epilepsy syndrome	7.63e-06	9.5e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC2A1—epilepsy syndrome	7.61e-06	9.48e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLCB1—epilepsy syndrome	7.53e-06	9.38e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TH—epilepsy syndrome	7.5e-06	9.34e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOE—epilepsy syndrome	7.47e-06	9.31e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCB1—epilepsy syndrome	7.43e-06	9.25e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.38e-06	9.2e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TSC2—epilepsy syndrome	7.24e-06	9.02e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOE—epilepsy syndrome	7.08e-06	8.82e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPX1—epilepsy syndrome	6.9e-06	8.6e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6ST—epilepsy syndrome	6.65e-06	8.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—epilepsy syndrome	6.6e-06	8.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SRC—epilepsy syndrome	6.56e-06	8.17e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—POMC—epilepsy syndrome	6.42e-06	8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—epilepsy syndrome	6.39e-06	7.96e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMOX1—epilepsy syndrome	6.26e-06	7.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAT—epilepsy syndrome	6.18e-06	7.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AGT—epilepsy syndrome	6.05e-06	7.54e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCB1—epilepsy syndrome	6.01e-06	7.49e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOE—epilepsy syndrome	5.93e-06	7.39e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—epilepsy syndrome	5.85e-06	7.29e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPX1—epilepsy syndrome	5.59e-06	6.96e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGF2—epilepsy syndrome	5.38e-06	6.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—epilepsy syndrome	5.12e-06	6.38e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—POMC—epilepsy syndrome	5.1e-06	6.35e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTOR—epilepsy syndrome	4.9e-06	6.1e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AGT—epilepsy syndrome	4.9e-06	6.1e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOE—epilepsy syndrome	4.8e-06	5.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—epilepsy syndrome	4.65e-06	5.79e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—POMC—epilepsy syndrome	4.12e-06	5.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—epilepsy syndrome	4.08e-06	5.08e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SRC—epilepsy syndrome	3.93e-06	4.89e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—epilepsy syndrome	3.29e-06	4.1e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.57e-06	3.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—epilepsy syndrome	2.44e-06	3.04e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—epilepsy syndrome	2.04e-06	2.55e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—epilepsy syndrome	1.65e-06	2.06e-05	CbGpPWpGaD
